PMIASEHealthcare·Medical Devices#90 in industry

Picard Medical, Inc.

Reports in 18d· 2026-05-15

-62.3% · 90d

$0.69

-0.16 (-18.44%)

After-Hours $0.70(+0.01)

News

(1)

April 2026

Apr 22, 20265 days ago8-KHealthcare

Picard Medical Reports 79.9% Revenue Growth in Q1 2026

PMIPicard Medical, Inc.

# 🧾 What This Document Is This is a **Form 8-K filing**, which a company uses to announce major news to investors. Attached to it is a press release (Exhibit 99.1) giving the details. In simple terms, Picard Medical is sharing its **preliminary revenue results** for the first three months of 2026 b

Read summaryView on SEC EDGAR

Key Data

Market Cap$51.9M

Open$0.80

Prev Close$0.85

Day Range$0.69 – $0.81

52W Range$0.69 – $13.68

Volume467,356

P/E (TTM)—

EPS$-0.75

Dividend Yield—

Beta—

Revenue Growth20.70%

Next Earnings2026-05-15(18d)

About

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Healthcare · Medical Devices

75 employees

www.picardmedical.com